Chemomab Therapeutics CMMB
NASDAQ CMMB
$2.16 +0.09 (+4.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Exchange Rate Effect (2018 - 2019)

Chemomab Therapeutics' (CMMB) quarterly Exchange Rate Effect came in at $25000.0 in Q3 2019, up 125.0% YoY from $11111.1 in Q3 2018, and down 83.55% on a QoQ basis from $152000.0 in Q4 2018.

Chemomab Therapeutics (CMMB) Exchange Rate Effect (2018 - 2019) Analysis & Trends

Chemomab Therapeutics (CMMB) has 2 years of Exchange Rate Effect data on file, last reported at $25000.0 in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -3.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -300,000.00
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -2.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 19.84 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -2.45 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 1.63 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -287,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Chemomab Therapeutics 13.62 Mn 3.25 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2019 25,000.00
Sep 30, 2019 25,000.00
Dec 31, 2018 152,000.00
Dec 31, 2018 152,000.00
Sep 30, 2018 -100,000.00
Sep 30, 2018 -100,000.00